Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease (NAFLD). NAFLD is caused by buildup of fat in the liver. When this buildup causes inflammation and damage, it is known as NASH, which can lead to scarring of the liver.
According to our Researcher latest study, the global Non-alcoholic Steatohepatitis market size was valued at USD 3277.4 million in 2022 and is forecast to a readjusted size of USD 11540 million by 2029 with a CAGR of 19.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Non-alcoholic Steatohepatitis market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Non-alcoholic Steatohepatitis market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Non-alcoholic Steatohepatitis market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Non-alcoholic Steatohepatitis market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Non-alcoholic Steatohepatitis market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-alcoholic Steatohepatitis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-alcoholic Steatohepatitis market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Arena Pharmaceuticals, GSK, Novo Nordisk and Roche, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Non-alcoholic Steatohepatitis market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Solid
Liquid
Market segment by Application
Oral
Parenteral
AstraZeneca
Arena Pharmaceuticals
GSK
Novo Nordisk
Roche
Vivus
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
Genfit
Gilead
Immuron
Interceptpharma
Raptor Pharmaceutical
Takeda
Tobira Therapeutics
Verva
Viking Therapeutics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Non-alcoholic Steatohepatitis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-alcoholic Steatohepatitis, with price, sales, revenue and global market share of Non-alcoholic Steatohepatitis from 2018 to 2023.
Chapter 3, the Non-alcoholic Steatohepatitis competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-alcoholic Steatohepatitis breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Non-alcoholic Steatohepatitis market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-alcoholic Steatohepatitis.
Chapter 14 and 15, to describe Non-alcoholic Steatohepatitis sales channel, distributors, customers, research findings and conclusion.
According to our Researcher latest study, the global Non-alcoholic Steatohepatitis market size was valued at USD 3277.4 million in 2022 and is forecast to a readjusted size of USD 11540 million by 2029 with a CAGR of 19.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Non-alcoholic Steatohepatitis market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Non-alcoholic Steatohepatitis market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Non-alcoholic Steatohepatitis market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Non-alcoholic Steatohepatitis market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/Kg), 2018-2029
Global Non-alcoholic Steatohepatitis market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-alcoholic Steatohepatitis
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-alcoholic Steatohepatitis market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Arena Pharmaceuticals, GSK, Novo Nordisk and Roche, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Non-alcoholic Steatohepatitis market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Solid
Liquid
Market segment by Application
Oral
Parenteral
Major players
coveredAstraZeneca
Arena Pharmaceuticals
GSK
Novo Nordisk
Roche
Vivus
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
Genfit
Gilead
Immuron
Interceptpharma
Raptor Pharmaceutical
Takeda
Tobira Therapeutics
Verva
Viking Therapeutics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-alcoholic Steatohepatitis product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Non-alcoholic Steatohepatitis, with price, sales, revenue and global market share of Non-alcoholic Steatohepatitis from 2018 to 2023.
Chapter 3, the Non-alcoholic Steatohepatitis competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-alcoholic Steatohepatitis breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Non-alcoholic Steatohepatitis market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Non-alcoholic Steatohepatitis.
Chapter 14 and 15, to describe Non-alcoholic Steatohepatitis sales channel, distributors, customers, research findings and conclusion.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
